374 related articles for article (PubMed ID: 23736035)
21. Role of Phytochemicals in Cancer Prevention.
Ranjan A; Ramachandran S; Gupta N; Kaushik I; Wright S; Srivastava S; Das H; Srivastava S; Prasad S; Srivastava SK
Int J Mol Sci; 2019 Oct; 20(20):. PubMed ID: 31600949
[TBL] [Abstract][Full Text] [Related]
22. Agents, biomarkers, and cohorts for chemopreventive agent development in prostate cancer.
Kelloff GJ; Lieberman R; Steele VE; Boone CW; Lubet RA; Kopelovich L; Malone WA; Crowell JA; Higley HR; Sigman CC
Urology; 2001 Apr; 57(4 Suppl 1):46-51. PubMed ID: 11295594
[TBL] [Abstract][Full Text] [Related]
23. Cancer chemoprevention.
Lippman SM; Benner SE; Hong WK
J Clin Oncol; 1994 Apr; 12(4):851-73. PubMed ID: 8151328
[TBL] [Abstract][Full Text] [Related]
24. From carcinogenesis to clinical interventions for cancer prevention.
Greenwald P
Toxicology; 2001 Sep; 166(1-2):37-45. PubMed ID: 11518609
[TBL] [Abstract][Full Text] [Related]
25. New opportunities in chemoprevention research.
Kucuk O
Cancer Invest; 2002; 20(2):237-45. PubMed ID: 11901544
[TBL] [Abstract][Full Text] [Related]
26. Chemoprevention of colon cancer: current status and future prospects.
Gustin DM; Brenner DE
Cancer Metastasis Rev; 2002; 21(3-4):323-48. PubMed ID: 12549770
[TBL] [Abstract][Full Text] [Related]
27. The retinoids and cancer prevention mechanisms.
Dragnev KH; Rigas JR; Dmitrovsky E
Oncologist; 2000; 5(5):361-8. PubMed ID: 11040271
[TBL] [Abstract][Full Text] [Related]
28. Chemoprevention of epithelial cancers.
Shureiqi I; Brenner DE
Curr Opin Oncol; 1999 Sep; 11(5):408-13. PubMed ID: 10505781
[TBL] [Abstract][Full Text] [Related]
29. The role of chemoprevention in cancer control.
Greenwald P; Kelloff GJ
IARC Sci Publ; 1996; (139):13-22. PubMed ID: 8923016
[TBL] [Abstract][Full Text] [Related]
30. Recent advances in chemoprevention of cancer.
Hong WK; Sporn MB
Science; 1997 Nov; 278(5340):1073-7. PubMed ID: 9353183
[TBL] [Abstract][Full Text] [Related]
31. Multiagent chemopreventive agent combinations.
Brenner DE
J Cell Biochem Suppl; 2000; 34():121-4. PubMed ID: 10762024
[TBL] [Abstract][Full Text] [Related]
32. Mechanistic considerations in the evaluation of chemopreventive data.
Kelloff GJ; Boone CW; Steele VE; Crowell JA; Lubet RA; Greenwald P; Hawk ET; Fay JR; Sigman CC
IARC Sci Publ; 1996; (139):203-19. PubMed ID: 8923032
[TBL] [Abstract][Full Text] [Related]
33. Chemoprevention of human cancer: a reasonable strategy?
Meyskens FL
Recent Results Cancer Res; 1999; 151():113-21. PubMed ID: 10337722
[TBL] [Abstract][Full Text] [Related]
34. Criteria of evidence to move potential chemopreventive agents into late phase clinical trials.
Kelly RJ; Lopez-Chavez A; Szabo E
Curr Drug Targets; 2011 Dec; 12(13):1983-8. PubMed ID: 21158704
[TBL] [Abstract][Full Text] [Related]
35. Can we prevent prostate cancer? Rationale and current status of prostate cancer chemoprevention.
Fujimoto N; Chang C; Nomura M; Matsumoto T
Urol Int; 2005; 74(4):289-97. PubMed ID: 15897691
[TBL] [Abstract][Full Text] [Related]
36. Chemoprevention: will it work?
Mettlin C
Int J Cancer; 1997; Suppl 10():18-21. PubMed ID: 9209015
[TBL] [Abstract][Full Text] [Related]
37. Chemoprevention: from research to clinical oncology.
Veronesi U; Bonanni B
Eur J Cancer; 2005 Sep; 41(13):1833-41. PubMed ID: 16061373
[TBL] [Abstract][Full Text] [Related]
38. Biomarker and animal models for assessment of retinoid efficacy in cancer chemoprevention.
Niles RM
Acta Pharmacol Sin; 2007 Sep; 28(9):1383-91. PubMed ID: 17723172
[TBL] [Abstract][Full Text] [Related]
39. Prostate cancer chemoprevention: Strategies for designing efficient clinical trials.
Lieberman R
Urology; 2001 Apr; 57(4 Suppl 1):224-9. PubMed ID: 11295633
[TBL] [Abstract][Full Text] [Related]
40. Dithiolethiones for cancer chemoprevention: where do we stand?
Zhang Y; Munday R
Mol Cancer Ther; 2008 Nov; 7(11):3470-9. PubMed ID: 19001432
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
